Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
63,404,675
-
Share change
-
+903,507
-
Total reported value
-
$5,702,460,810
-
Put/Call ratio
-
94%
-
Price per share
-
$89.94
-
Number of holders
-
244
-
Value change
-
+$81,264,345
-
Number of buys
-
5
-
Number of sells
-
6
Institutional Holders of SALIX PHARMACEUTICALS INC - COM (SLXP) as of Q4 2013
As of 31 Dec 2013,
SALIX PHARMACEUTICALS INC - COM (SLXP) was held by
244 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,404,675 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT CO LLP, VANGUARD GROUP INC, Bank of New York Mellon Corp, BlackRock Fund Advisors, TIAA CREF INVESTMENT MANAGEMENT LLC, Ameriprise Financial Inc, State Street Corp, TimesSquare Capital Management, LLC, and FEDERATED INVESTORS INC /PA/.
This page lists
244
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.